Peru positions itself as a regional leader in good regulatory practices

Peru is emerging as one of Latin America’s most proactive countries in strengthening its regulatory system for pharmaceuticals and health products, according to a recent study published in the Peruvian journal Science, Policy and Pharmaceutical Regulation.

Researchers say the country has made significant progress in adopting good regulatory practices (GRPs), and has the potential to become a regional benchmark — provided it continues to address remaining gaps in resources, technical capacity, and alignment with international standards.

The work, led by the Institute of Foresight and Innovation in Health (INNOS) — a joint think tank created by the Association of Pharmaceutical Laboratories for Research and Development (Afidro) and Universidad El Bosque in Colombia — underscores that GRPs are essential for advancing regulatory maturity, ensuring more equitable access to medicines, and accelerating the introduction of new technologies.